WallStreetZenWallStreetZen

NASDAQ: CSII
CARDIOVASCULAR SYSTEMS INC Stock Forecast, Predictions & Price Target

Analyst price target for CSII

Based on 1 analyst offering 12 month price targets for CARDIOVASCULAR SYSTEMS INC.
Min Forecast
$20.00+22.7%
Avg Forecast
$20.00+22.7%
Max Forecast
$20.00+22.7%

Should I buy or sell CSII stock?

Based on 4 analysts offering ratings for CARDIOVASCULAR SYSTEMS INC.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 25%
Hold
3 analysts 75%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

CSII stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
SVB Leerink
Bottom 2%
2
BuyMaintains$20.00+22.70%2022-05-05
Needham
Bottom 1%
1
HoldDowngradesN/AN/A2021-11-17
Guggenheim
Bottom 17%
17
HoldDowngradesN/AN/A2021-11-10
Barclays
Bottom 15%
15
HoldInitiates Coverage OnN/AN/A2021-05-25

1 of 1

Forecast return on equity

Is CSII forecast to generate an efficient return?
Company
-6.6%
Industry
26.86%
Market
30.86%
CSII's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CSII forecast to generate an efficient return on assets?
Company
-5.16%
Industry
14.03%
CSII is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CSII earnings per share forecast

What is CSII's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$0.91
Avg 2 year Forecast
-$0.76
Avg 3 year Forecast
-$0.48

CSII revenue forecast

What is CSII's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$236.2M-3.47%
Avg 2 year Forecast
$261.0M+6.64%
Avg 3 year Forecast
$291.4M+19.07%
CSII's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CSII revenue growth forecast

How is CSII forecast to perform vs Medical Devices companies and vs the US market?
Company
5.85%
Industry
5.76%
Market
8.91%
CSII's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CSII's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CSII vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
CSII$16.30$20.00+22.70%Hold
LUNG$18.63$37.00+98.60%Strong Buy
QTRX$16.57$52.50+216.84%Strong Buy
ZIMV$23.02N/AN/AHold
AORT$18.29$30.00+64.02%Buy

CARDIOVASCULAR SYSTEMS Stock Forecast FAQ

Is CARDIOVASCULAR SYSTEMS Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CSII) stock is to Hold CSII stock.

Out of 4 analysts, 0 (0%) are recommending CSII as a Strong Buy, 1 (25%) are recommending CSII as a Buy, 3 (75%) are recommending CSII as a Hold, 0 (0%) are recommending CSII as a Sell, and 0 (0%) are recommending CSII as a Strong Sell.

What is CSII's earnings growth forecast for 2022-2024?

(NASDAQ: CSII) CARDIOVASCULAR SYSTEMS's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.71%.

CARDIOVASCULAR SYSTEMS's earnings in 2022 is -$32,528,000.On average, 6 Wall Street analysts forecast CSII's earnings for 2022 to be -$37,114,462, with the lowest CSII earnings forecast at -$38,745,867, and the highest CSII earnings forecast at -$35,075,206. On average, 6 Wall Street analysts forecast CSII's earnings for 2023 to be -$30,996,693, with the lowest CSII earnings forecast at -$47,310,743, and the highest CSII earnings forecast at -$24,471,074.

In 2024, CSII is forecast to generate -$19,576,859 in earnings, with the lowest earnings forecast at -$29,773,140 and the highest earnings forecast at -$8,972,727.

What is CSII's revenue growth forecast for 2022-2024?

(NASDAQ: CSII) CARDIOVASCULAR SYSTEMS's forecast annual revenue growth rate of 5.85% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.91%.

CARDIOVASCULAR SYSTEMS's revenue in 2022 is $244,713,000.On average, 5 Wall Street analysts forecast CSII's revenue for 2022 to be $9,634,139,400, with the lowest CSII revenue forecast at $9,596,250,020, and the highest CSII revenue forecast at $9,686,058,861. On average, 5 Wall Street analysts forecast CSII's revenue for 2023 to be $10,643,040,987, with the lowest CSII revenue forecast at $10,426,716,695, and the highest CSII revenue forecast at $10,881,470,816.

In 2024, CSII is forecast to generate $11,884,336,206 in revenue, with the lowest revenue forecast at $11,292,992,707 and the highest revenue forecast at $12,341,578,220.

What is CSII's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: CSII) forecast ROA is -5.16%, which is lower than the forecast US Medical Devices industry average of 14.03%.

What is CSII's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CSII price target, the average CSII price target is $20.00, with the highest CSII stock price forecast at $20.00 and the lowest CSII stock price forecast at $20.00.

The Wall Street analyst predicted that CARDIOVASCULAR SYSTEMS's share price could reach $20.00 by May 5, 2023. The average CARDIOVASCULAR SYSTEMS stock price prediction forecasts a potential upside of 22.7% from the current CSII share price of $16.30.

What is CSII's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: CSII) CARDIOVASCULAR SYSTEMS's current Earnings Per Share (EPS) is -$0.84. On average, analysts forecast that CSII's EPS will be -$0.91 for 2022, with the lowest EPS forecast at -$0.95, and the highest EPS forecast at -$0.86. On average, analysts forecast that CSII's EPS will be -$0.76 for 2023, with the lowest EPS forecast at -$1.16, and the highest EPS forecast at -$0.60. In 2024, CSII's EPS is forecast to hit -$0.48 (min: -$0.73, max: -$0.22).

What is CSII's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: CSII) forecast ROE is -6.6%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.